Fiche personne


Territoire

Bourgogne

Statut

Hospitalo-Universitaire

Projets


Publications


Early Positron Emission Tomography Response-Adapted Treatment in Low-Risk Diffuse Large B-Cell lymphoma: an open label, multicenter, randomised, non-inferiority phase 3 trial.

Michot JM, Bologna S, Bastie JN, Borght TV, Brière J, Ribrag V, Bommier C, Peyrade F, Lebras L, Damaj G, Coso D, Sibon D, Bonnet C, Morschhauser F, Ghesquières H, Fruchart C, Soussain C, Becker S, Olivier P, Julian A, Molina T, Haioun C, Tilly H

Ann Oncol. 2025 11 17;:

Assessing the benefit of incorporating an anti-CD38 monoclonal antibody into second- or third-line systemic treatment for patients with relapsed/refractory multiple myeloma: results from the French real-world EMMY study.

Chalopin T, Hulin C, Royer B, Bastie JN, Bobin A, Merzoug KB, Macro M, Karlin L, Jacquet C, Mohty M, Frenzel L, Sonntag C, Fontan J, Rigaudeau S, Roussel M, Sanhes L, Chaoui D, Vincent L, Orfeuvre H, Bouketouche M, Garlantezec R, Decaux O, Perrot A

Haematologica. 2025 08 28;:

The Impact of Anti-CD38 Monoclonal Antibodies in Frontline Therapy for Patients With Newly Diagnosed Multiple Myeloma: Real-Life Results From the EMMY Study.

Chalopin T, Decaux O, Hulin C, Perrot A, Macro M, Royer B, Bastie JN, Bobin A, Jacquet C, Mohty M, Frenzel L, Sonntag C, Roussel M, Sanhes L, Chaoui D, Dib M, Slama B, Richez V, Montes L, Dervite I, Laribi K, Re D, Garlantezec R, Merzoug KB, Vincent L

Clin Lymphoma Myeloma Leuk. 2025 07 24;:

Voir plus